Corcept Therapeutics (CORP) stock plummeted 48% in its worst intraday performance in 11 years, signaling a potential fundamental crisis at the company.
On December 31, Shandong Zhanggu Blower disclosed it is under investigation by the China Securities Regulatory Commission for suspected illegal financial reporting.
Investment bank KBW upgraded TeraWulf (WULF) to "outperform" and more than doubled its price target to $24, citing the company's strategic pivot from bitcoin mining to AI and high-performance computing.